| 688185 Stock | | | 61.23 0.13 0.21% |
Founder
Dongxu MBA is Executive CoFounder of Cansino Biologics
| Age | 64 |
| Address | 401-420, Biomedical Park, Tianjin, China, 300457 |
| Phone | 86 022 5821 3600 |
| Web | https://www.cansinotech.com |
Cansino Biologics Management Efficiency
The company has return on total asset
(ROA) of
(0.0792) % which means that it has lost $0.0792 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.1362) %, meaning that it generated substantial loss on money invested by shareholders. Cansino Biologics' management efficiency ratios could be used to measure how well Cansino Biologics manages its routine affairs as well as how well it operates its assets and liabilities. At present, Cansino Biologics'
Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's
Other Assets is expected to grow to about 481.5
M, whereas
Total Assets are forecasted to decline to about 6.7
B.
Cansino Biologics (688185) is traded on Shanghai Stock Exchange in China and employs 1,494 people. Cansino Biologics is listed under Pharmaceuticals category by Fama And French industry classification.
Management Performance
Cansino Biologics Leadership Team
Elected by the shareholders, the Cansino Biologics' board of directors comprises two types of representatives: Cansino Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cansino. The board's role is to monitor Cansino Biologics' management team and ensure that shareholders' interests are well served. Cansino Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cansino Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yonghui Wu, Vice Marketing | |
| Jin Cui, Board Secretary | |
| Xuefeng Yu, Chairman, CoFounder | |
| Tao Zhu, Deputy CoFounder | |
| Chunlin Xin, Director Department | |
| Xi Luo, Chief Officer | |
| FCS FCIS, Joint Secretary | |
| Dongxu MBA, Executive CoFounder | |
| Jing Wang, Deputy Officer | |
| ShouBai Chao, COO Director | |
Cansino Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cansino Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Cansino Stock
Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.